European Archives - Page 248 of 1269 - European Medical Journal

Lungs

Qureight and Avalyn unite to advance pulmonary fibrosis treatment

Two companies have come together to enhance the way imaging technology is used to assess treatment responses in progressive pulmonary fibrosis.

New Risk Score Uses Stress Levels to Improve Heart Disease Prediction

A novel cardiovascular risk score improves prediction of heart disease by assessing stress-related changes in vascular function.

Optic Neuropathy Concerns with Popular Antidiabetic Drugs

Ophthalmic complications linked to semaglutide and tirzepatide raise concerns for diabetic patients on these medications.

Joint-Specific Responses to TNFi in Psoriatic Arthritis Revealed in European Study

A study of over 1,700 psoriatic arthritis patients across nine European countries reveals that tumor necrosis factor inhibitors (TNFi) work differently depending on the affected joint.

Understanding Biological Mechanisms Behind Postpartum Depression

One promising area of research revolves around neuroactive steroids (NAS), which are metabolites of cholesterol that can influence brain activity.

Overexpression of RAD51 Family Genes Linked to Poorer Breast Cancer Prognosis

Overexpression of RAD51 genes correlates with poorer prognosis in breast cancer, highlighting its potential as a prognostic biomarker and therapeutic target.

Blood Biomarkers Predict COVID-19 Mortality in Patients with Cancer

Research has identified microRNAs as potential biomarkers for predicting COVID-19-related mortality in patients with cancer.

Scientists Identify Gut Microbiome Signatures for NAFLD Diagnosis and Treatment

New research published in has identified highly specific gut microbiome signatures linked to non-alcoholic fatty liver disease (NAFLD).

The Second Brain: Transforming Gut Healing: Part 1

In this episode of the EMJ Podcast, host Jonathan Sackier welcomes Douglas Drossman, a pioneer in disorders of gut–brain interaction.

Latine Patients Face Barriers to Psoriasis Treatment Access

A recent qualitative study has provided valuable insights into the experiences of Latine patients in the US living with moderate to severe psoriasis.